Treatment Efficacy and Safety Analysis of Tamsulosin Application for Advanced Prostate cancer

Yu ZHU,Zongming LIN,Jianping ZHANG,Lei XU,Le XU,Wenping XU,Hankun YIN,Guomin WANG
DOI: https://doi.org/10.3969/j.issn.1001-1420.2011.02.033
2011-01-01
Journal of Clinical Urology
Abstract:Objective:To evaluate and investigate the treatment efficacy and safety of tamsulosin application for the treatment of advanced prostate cancer associated with lower urinary tract symptoms(LUTS).Methods:January 2009-October 2010.76 patients with advanced prostate cancer in our department who have LUTS、normal blood pressure and whose international prostate symptom score(IPSS) were more than 20 points,are randomly divided into treatment group(T) and control group(C).Both groups were treated with Maximal androgen blockade (MAB),and T group also combined with super-selectiveα1A receptor antagonist for treatment.Results:after 4 weeks and 8 weeks treatment,international prostate symptom score(IPSS),quality of life index scoresmaximum urinary flow rate,prostate volume(V),residual urine volume(Ru) were much improvement in T group compared with the C group(P<0.05).Blood pressure variation was no significant difference(P>0.05).Treatment for 4 weeks and 8 weeks showed no significant difference(PX).05).Conclusions:MAB treatment may prolong progression -free survival of patients of advanced prostate cancer,tamsulosin may be effective in improving symptoms and quality of life in these patients who had LUTS with very little adverse reactions.
What problem does this paper attempt to address?